RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,726,035 | -52.3% | 2,107,733 | -28.7% | 0.00% | -33.3% |
| Q2 2023 | $37,130,135 | -87.2% | 2,956,221 | -83.2% | 0.00% | -76.9% |
| Q1 2023 | $290,102,294 | +99.5% | 17,613,982 | +81.0% | 0.01% | -7.1% |
| Q4 2022 | $145,423,690 | -45.6% | 9,733,848 | -18.6% | 0.01% | -50.0% |
| Q3 2022 | $267,505,000 | +19.8% | 11,958,212 | -10.3% | 0.03% | +27.3% |
| Q2 2022 | $223,362,000 | -54.1% | 13,335,055 | -17.9% | 0.02% | -43.6% |
| Q1 2022 | $486,123,000 | -2.3% | 16,242,006 | +0.2% | 0.04% | +5.4% |
| Q4 2021 | $497,705,000 | +15.3% | 16,206,601 | +18.4% | 0.04% | +8.8% |
| Q3 2021 | $431,545,000 | +13.8% | 13,686,804 | +32.1% | 0.03% | +13.3% |
| Q2 2021 | $379,145,000 | +88.2% | 10,362,000 | +77.8% | 0.03% | +76.5% |
| Q1 2021 | $201,489,000 | +1.8% | 5,828,452 | +22.4% | 0.02% | -5.6% |
| Q4 2020 | $197,918,000 | -3.5% | 4,762,238 | -1.1% | 0.02% | -14.3% |
| Q3 2020 | $205,109,000 | – | 4,815,879 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |